Aciont Inc   Report issue

For profit Phase 2
Founded: Salt Lake City UT United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2014
NCT02309385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

prednisone (meticorten) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Iridocyclitis (Phase 2)

Uveitis (Phase 2)

Uveitis, Anterior (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2